SRPT

Sarepta Therapeutics News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Sarepta Therapeutics Inc New SRPT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 85.63 07:00:00
Open Price Low Price High Price Close Price Prev Close
85.63
more quote information »

Recent News

Date Time Source Heading
9/16/20218:07IHNWFeaturedFandom Sports Appoints Lyle Strachan as Chief Financial Officer
9/16/202111:39IHNWFeaturedNeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
9/14/202108:30GLOBESarepta Therapeutics to Showcase Data from its Gene Therapy..
9/07/202116:30GLOBESarepta Therapeutics to Present at Upcoming Investor..
9/07/202108:30GLOBESarepta Therapeutics Announces Recipients of Route 79, The..
8/31/202117:57GLOBESarepta Therapeutics Announces Inducement Grants Under..
8/23/202108:03SEEKTakeda in pact with Genevant for nonviral gene therapies..
8/10/202112:22EDGARSchedule 13g
8/04/202116:35SEEKSarepta Therapeutics narrows Q2 net loss thanks to one-off..
8/04/202116:16SEEKSarepta Therapeutics EPS misses by $0.23, beats on revenue
8/04/202116:05GLOBESarepta Therapeutics Announces Second Quarter 2021 Financial..
8/04/202116:04EDGARQuarterly Report (10-q)
8/04/202108:40SEEKSarepta executes licensing agreement for gene therapy..
8/04/202108:30GLOBESarepta Therapeutics Executes Licensing Agreement for Gene..
7/30/202117:42GLOBESarepta Therapeutics Announces Inducement Grants Under..
7/28/202108:30GLOBESarepta Therapeutics to Announce Second Quarter 2021..
6/30/202118:40GLOBESarepta Therapeutics Announces Inducement Grants Under..
6/03/202117:01EDGARCurrent Report Filing (8-k)
6/03/202116:58EDGARStatement of Changes in Beneficial Ownership (4)
6/03/202116:30GLOBESarepta Therapeutics to Present at Upcoming Investor..
5/28/202118:55GLOBESarepta Therapeutics Announces Inducement Grants Under..
5/18/202112:38SEEKSarepta keeps momentum as DMD data draw positive views from..
5/18/202108:58EDGARCurrent Report Filing (8-k)
5/18/202108:50GLOBESarepta Therapeutics’ Investigational Gene Therapy for the..
5/17/202116:05GLOBESarepta Therapeutics to Share Expression and Safety Results..
5/05/202116:41SEEKSarepta's Q1 sales surge 24%, beat earnings estimates
5/05/202116:13SEEKSarepta Therapeutics EPS beats by $0.03, beats on revenue
5/05/202116:05GLOBESarepta Therapeutics Announces First Quarter 2021 Financial..
5/05/202116:03EDGARQuarterly Report (10-q)
5/04/202117:35SEEKSarepta Therapeutics Q1 2021 Earnings Preview
5/04/202116:30GLOBESarepta Therapeutics to Present at Upcoming Investor..
5/03/202109:19SEEKSarepta releases positive data on muscular dystrophy drug,..
5/03/202108:53EDGARCurrent Report Filing (8-k)
5/03/202108:50GLOBESarepta Therapeutics Reports Positive Clinical Results from..
5/03/202108:02GLOBEMIMEDX Files Definitive Proxy Materials and Mails Letter to..
4/30/202118:45GLOBESarepta Therapeutics Announces Inducement Grants Under..
4/30/202116:05GLOBESarepta Therapeutics to Share Clinical Update for 30 mg/kg..
4/28/202108:30GLOBESarepta Therapeutics to Announce First Quarter 2021..
4/26/202116:52SEEKSarepta recommends stockholders reject TRC capital's mini..
4/26/202116:05GLOBESarepta Recommends Stockholders Reject the Below-Market..
4/20/202116:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/20/202116:11EDGARProxy Statement (definitive) (def 14a)
3/31/202114:35DJNJohn Martin, Who Built Gilead Into HIV, Hepatitis..
3/23/202108:30GLOBESarepta Therapeutics Announces Fourth Year of Route 79, The..
3/19/202116:15SEEKSarepta’s latest muscular dystrophy trial results viewed..
3/18/202116:51SEEKSarepta posts new results from SRP-9003 muscular dystrophy..
3/18/202116:31GLOBESarepta Therapeutics’ Investigational Gene Therapy SRP-9003..
3/15/202108:30GLOBESarepta Therapeutics to Present Results from its Gene..
3/01/202116:47SEEKSarepta slides on revenue miss
3/01/202116:09SEEKSarepta Therapeutics EPS misses by $0.38, misses on revenue
3/01/202116:05GLOBESarepta Therapeutics Announces Fourth Quarter and Full-Year..
3/01/202116:04EDGARAnnual Report (10-k)
See more news about this stock »


Your Recent History
NASDAQ
SRPT
Sarepta Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.